The North America Coronary Artery Bypass Graft Market would witness market growth of 8.4% CAGR during the forecast period (2023-2029).
The purpose of coronary artery bypass graft surgery is to remove obstructions that impede blood flow. The procedure bypasses blood flow by grafting a vein or blood vessel from the thigh. Depending on the number of blocks, one or more grafts may be employed. CABG surgery is performed to enhance life quality and lessen angina and other cardiovascular illnesses symptoms. The market is driven by an increase in endoscopic procedures, an increase in cardiovascular disease incidence, demographic shifts, comorbidities, including obesity and stress brought on by sedentary lifestyles and an aging population, and a rise in medical tourism.
The main causes of cardiovascular diseases (CVDs) in people include stress, sedentary lifestyles, and junk food consumption. The market is expected to develop faster throughout the projection period due to the rising senior population, which is projected to be a primary driver of more coronary artery bypass graft procedures.
According to CDC data, heart disease remains the primary cause of death for women, men, and most ethnic and racial minorities in the United States. One person dies from cardiovascular disease in the US every 34 seconds. In the United States, heart disease killed 697,000 lives in 2020, accounting for 1 in 5 fatalities. In addition, heart disease cost the US economy about $229 billion in 2017 and 2018. In the United States, healthcare costs have risen dramatically over the previous few decades. In addition, both pricing and demand for medical services have increased due to government programs like Medicare and Medicaid. These factors are anticipated to aid in the regional market's expansion.
The US market dominated the North America Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $6,432.6 million by 2029. The Canada market is showcasing a CAGR of 10.9% during (2023 - 2029). Additionally, The Mexico market would exhibit a CAGR of 9.9% during (2023 - 2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Coronary Artery Bypass Graft Market is Projected to reach USD 20.6 Billion by 2029, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
By Procedure
By Method
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 